Erythrocytes Induce Endothelial Injury in Type 2 Diabetes Through Alteration of Vascular Purinergic Signaling
It is well established that altered purinergic signaling contributes to vascular dysfunction in type 2 diabetes (T2D). Red blood cells (RBCs) serve as an important pool for circulating ATP and the release of ATP from RBCs in response to physiological stimuli is impaired in T2D. We recently demonstra...
Main Authors: | Ali Mahdi, Yahor Tratsiakovich, John Tengbom, Tong Jiao, Lara Garib, Michael Alvarsson, Jiangning Yang, John Pernow, Zhichao Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.603226/full |
Similar Items
-
Editorial: Purinergic pharmacology, Volume II
by: Francisco Ciruela, et al.
Published: (2023-05-01) -
Editorial: Purinergic Pharmacology
by: Francisco Ciruela, et al.
Published: (2019-01-01) -
The role of purinergic signaling in microglial responses
by: Yaling Hu, et al.
Published: (2021-01-01) -
Single-cell RNA sequencing reveals distinct transcriptional features of the purinergic signaling in mouse trigeminal ganglion
by: Shilin Jia, et al.
Published: (2022-10-01) -
Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives
by: Rosa Gomez-Villafuertes, et al.
Published: (2020-07-01)